Rachel H Harrigan, Age 6124 Wakefield Rd, Branford, CT 06405

Rachel Harrigan Phones & Addresses

24 Wakefield Rd, Branford, CT 06405 (203) 433-4571

New York, NY

13 Park Dr, Waterford, CT 06385 (860) 447-2107

Groton, CT

New London, CT

Stonington, CT

East Lyme, CT

Old Saybrook, CT

220 E 63Rd St Ph B, New York, NY 10065 (860) 447-2107

Show more

Mentions for Rachel H Harrigan

Rachel Harrigan resumes & CV records

Resumes

Rachel Harrigan Photo 22

Medical Doctor

Location:
New York, NY
Industry:
Pharmaceuticals
Work:
Harrigan Consulting
Self Employed
Harrigan Consulting
Medical Doctor
Education:
The University of Manchester 1981 - 1986
Bachelors, Bachelor of Medicine, Medicine
The University of Manchester;Mb Chb, Medicine;1981 – 1986;
Bachelors, Bachelor of Medicine, Medicine
Skills:
Leadership, Development, Clinical Trials, Medical Writing, Cro, Cardiology, Neurology, Infectious Diseases, Ctms, Biotechnology, Regulatory Affairs, Life Sciences, Operations, Pharmacovigilance, Drug Discovery, Lifesciences, Oncology, Drug Development, Gcp, Clinical Development, Pharmaceutics, Regulatory Submissions, Vaccines, Pharmacology, Diabetes, Pharmaceutical Industry, Sop
Rachel Harrigan Photo 23

Rachel Harrigan

Skills:
Pmp, Pe, Project Management

Publications & IP owners

Us Patents

Method For Treating Pediatric Bipolar Disorder

US Patent:
2008026, Oct 30, 2008
Filed:
Apr 28, 2008
Appl. No.:
12/110522
Inventors:
Steven Joseph Romano - New York NY, US
Rachel Heather Harrigan - Old Lyme CT, US
International Classification:
A61K 31/496
A61P 25/00
US Classification:
51425404
Abstract:
The present invention, in one aspect, relates to a method of using piperazinyl-heterocyclic compounds of the formula I, as defined below, for enhancing cognition in a mammal, including a human, for example a mammal afflicted with psychosis, autism, dementia, or mental retardation, comprising administering an effective amount of a compound of formula I (for example, ziprasidone) to the mammal. In another aspect, the present invention is directed to a method for reducing or ameliorating in a mammal, including a human, afflicted with a disorder or condition selected from autism, mental retardation, obsessive-compulsive disorder, and dementia, positive symptoms (e.g. excessive aggression, disinhibited sexual behavior, inappropriate sexual behavior, agitation, compulsive behavior such as head banging, lip biting, self mutilation, or stereotypic behavior) associated with the aforementioned disorders or conditions, which method comprises administering an effective amount of a compound of formula I (for example, ziprasidone) to the mammal. In another aspect, the present invention is directed to a method for treating pediatric bipolar disorder in a mammal, including a human, which method comprises administering an effective amount of a compound of formula I (for example, ziprasidone) to the mammal.The compounds of the formula I are defined as follows:or a pharmaceutically acceptable acid addition salt thereof, wherein Ar, n, X, and Y are as defined.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.